Nephritic Syndrome - Causes, Treatment & When to See a Doctor

What is Nephritic Syndrome?

Nephritic syndrome is a collection of signs and laboratory abnormalities that result from inflammation of the glomeruli—the tiny filtering units of the kidneys. The inflammation damages the glomerular basement membrane, allowing red blood cells and protein to leak into the urine. Because the kidneys cannot filter blood efficiently, patients often develop reduced urine output, swelling (edema), and high blood pressure.

The term “nephritic” distinguishes this pattern from nephrotic syndrome, which is dominated by massive protein loss and severe edema but usually lacks hematuria. In practice, many patients exhibit features of both syndromes, and the distinction is made based on the predominant findings.

Typical laboratory findings include:

• Hematuria (blood in urine), often with red‑blood‑cell casts
• Moderate proteinuria (usually <1 g/24 h)
• Elevated serum creatinine and blood urea nitrogen (BUN)
• Decreased complement levels in certain immune‑mediated causes

Nephritic syndrome can affect children, adolescents, or adults, and the underlying cause determines the speed of progression and the long‑term outlook.

Common Causes

Inflammation of the glomeruli can be triggered by a variety of diseases. The most frequent culprits are:

• Post‑streptococcal glomerulonephritis (PSGN) – follows a throat or skin infection with Group A Streptococcus.
• IgA nephropathy (Berger disease) – deposition of IgA antibodies in the glomeruli; the leading cause of primary glomerulonephritis worldwide.
• Lupus nephritis – systemic lupus erythematosus (SLE) causing immune‑complex deposition.
• Membranoproliferative glomerulonephritis (MPGN) – classified into types I–III, often associated with complement dysregulation.
• Rapidly progressive (crescentic) glomerulonephritis – includes anti‑GBM disease (Goodpasture syndrome) and ANCA‑associated vasculitides.
• Henoch‑Schönlein purpura (IgA vasculitis) – a small‑vessel vasculitis that frequently involves kidneys.
• Infection‑related glomerulonephritis – hepatitis B, hepatitis C, HIV, or bacterial endocarditis.
• Drug‑induced nephritis – e.g., NSAIDs, penicillamine, gold salts.
• Scleroderma renal crisis – a severe complication of systemic sclerosis.
• Complement factor H deficiency or atypical hemolytic‑uremic syndrome (aHUS) – genetic or acquired complement pathway abnormalities.

Associated Symptoms

Patients with nephritic syndrome often notice a cluster of symptoms that reflect both kidney dysfunction and the underlying disease process:

• Hematuria: Cola‑colored or tea‑colored urine; microscopic blood may be detected on a dipstick.
• Proteinuria: Foamy urine, though generally less dramatic than in nephrotic syndrome.
• Reduced urine output (oliguria) or difficulty urinating.
• Swelling (edema): Usually periorbital in the morning, later progressing to ankles and feet.
• Hypertension: Elevated blood pressure due to fluid retention and activation of the renin‑angiotensin system.
• Pain: Flank or lower‑back discomfort caused by kidney inflammation.
• General malaise, fatigue, and decreased appetite.
• Fever or rash if the underlying cause is infectious or vasculitic (e.g., Henoch‑Schönlein purpura).

When to See a Doctor

Because kidney inflammation can progress rapidly, early medical evaluation is crucial. Seek care promptly if you experience any of the following:

• Dark, tea‑colored urine or visible blood in the urine.
• Sudden swelling of the face, eyes, or lower extremities.
• New or worsening high blood pressure (≥140/90 mm Hg).
• Decreased urination or a feeling that the bladder is not completely empty.
• Painful urination, flank pain, or a fever following a sore throat or skin infection.
• Persistent fatigue, nausea, or loss of appetite accompanied by the above signs.

Even if symptoms seem mild, an evaluation is important because many underlying diseases (e.g., lupus or vasculitis) can cause damage to other organs if left untreated.

Diagnosis

Diagnosing nephritic syndrome involves a stepwise approach that combines history, physical examination, laboratory testing, imaging, and sometimes kidney biopsy.

1. Clinical History & Physical Exam

• Recent infections (strep throat, skin sores), medication use, or known autoimmune disease.
• Blood pressure measurement and assessment for edema.

2. Laboratory Studies

• Urinalysis: Detects hematuria, red‑blood‑cell casts, protein, and sometimes white blood cells.
• Urine protein quantification: 24‑hour collection or spot urine protein/creatinine ratio.
• Serum chemistry: Creatinine, BUN, electrolytes, calcium, phosphorus.
• Complement levels (C3, C4): Low C3 suggests post‑streptococcal or MPGN.
• Autoimmune serologies: ANA, anti‑dsDNA (lupus), ANCA (vasculitis), anti‑GBM antibodies.
• Infectious work‑up: ASO titer, throat culture, hepatitis serologies, HIV test if risk factors present.

3. Imaging

• Renal ultrasound: Evaluates kidney size, obstruction, and cortical echogenicity.
• CT or MRI is rarely needed unless an alternative diagnosis (e.g., renal artery stenosis) is suspected.

4. Kidney Biopsy

When the cause cannot be identified by non‑invasive tests, a biopsy provides definitive histologic diagnosis. Light microscopy, immunofluorescence, and electron microscopy can differentiate among IgA nephropathy, lupus nephritis, MPGN, and crescentic GN, guiding therapy.

Treatment Options

Therapy aims to control inflammation, manage complications, and preserve kidney function. Treatment plans are individualized based on the underlying cause, disease severity, and patient age.

1. General Measures

• Blood pressure control: ACE inhibitors or ARBs are first‑line; they also reduce proteinuria.
• Fluid and salt restriction: 1.5–2 g of sodium per day to limit edema and hypertension.
• Diuretics (e.g., furosemide): Help reduce edema when fluid overload is present.
• Dietary protein moderation: 0.8–1.0 g/kg/day to lessen kidney workload (especially if chronic kidney disease develops).

2. Disease‑Specific Therapies

• Post‑streptococcal GN: Primarily supportive; antibiotics to eradicate residual streptococcal infection, and steroids are usually not required.
• IgA nephropathy: Blood pressure control, possibly a short course of steroids or fish‑oil supplements; emerging data support targeted immunosuppression for high‑risk patients.
• Lupus nephritis: High‑dose corticosteroids plus either mycophenolate mofetil or cyclophosphamide; maintenance with azathioprine or mycophenolate.
• ANCA‑associated vasculitis: Induction with pulse methylprednisolone + rituximab or cyclophosphamide; maintenance with low‑dose steroids and azathioprine or rituximab.
• Anti‑GBM disease (Goodpasture): Plasmapheresis combined with high‑dose steroids and cyclophosphamide.
• MPGN (immune‑complex type): Treat underlying infection or autoimmune disease; consider steroids and rituximab for refractory cases.
• Drug‑induced nephritis: Immediate discontinuation of the offending agent; steroids may hasten recovery.

3. Supportive Care for Complications

• Manage hyperkalemia or acidosis with oral binders or dialysis if severe.
• Vaccinations (influenza, pneumococcal, hepatitis B) especially in patients receiving immunosuppression.
• Educate about signs of infection, as steroids and other agents increase susceptibility.

4. When Dialysis Is Needed

If creatinine rises sharply, severe fluid overload, refractory hyperkalemia, or uremic symptoms (e.g., nausea, pericarditis) develop, temporary or permanent renal replacement therapy may be required.

Prevention Tips

While not all cases of nephritic syndrome are preventable, certain strategies can reduce risk:

• Prompt treatment of streptococcal throat or skin infections with appropriate antibiotics.
• Good oral hygiene and regular dental care to lower risk of bacterial endocarditis‑related GN.
• Vaccination against hepatitis B and HIV prevention measures.
• Avoid unnecessary prolonged use of NSAIDs or other nephrotoxic drugs; use the lowest effective dose.
• Control chronic autoimmune diseases (e.g., lupus) with regular rheumatology follow‑up.
• Screen high‑risk family members for complement disorders if a hereditary atypical HUS is suspected.
• Maintain a healthy blood pressure and blood sugar level to protect kidney health overall.

Emergency Warning Signs

Key Take‑aways

Nephritic syndrome signals inflammation of the kidney’s filtering structures and can arise from infections, immune disorders, or drugs. Early recognition, accurate diagnosis, and tailored treatment—often involving blood‑pressure control and immunosuppression—are essential to preserve kidney function and prevent lifelong complications. When in doubt, especially with dark urine, swelling, or rapidly worsening blood pressure, consult a healthcare professional promptly.

References:

• Mayo Clinic. “Nephritic syndrome.” Updated 2023. https://www.mayoclinic.org
• National Kidney Foundation. “Glomerulonephritis.” Accessed 2024. https://www.kidney.org
• American College of Rheumatology. “Management of Lupus Nephritis.” 2023 guidelines.
• Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Glomerulonephritis, 2022.
• Centers for Disease Control and Prevention. “Post‑streptococcal glomerulonephritis.” 2022.